This page contains a Flash digital edition of a book.
Consider Tecfidera—a pill that has the strength to cut relapses in half.*


Tecfidera is an oral treatment for relapsing multiple sclerosis (MS). It has been shown to not only cut relapses in half, but also slow the development of brain lesions and delay the progression of physical disability. Thousands of people around the world have taken Tecfidera. Ask your doctor if you should too.


Tecfidera (dimethyl fumarate) is a prescription medicine used to treat people with relapsing forms of multiple sclerosis.


Important Safety Information Before taking and while you take Tecfidera, tell your doctor about any low white blood cell counts or infections or any other medical conditions.


What are the possible side effects of Tecfidera? Tecfidera may cause serious side effects including decreases in your white blood cell count. Your doctor may check your white blood cell count before you take Tecfidera and from time to time during treatment.


The most common side effects of Tecfidera include flushing and stomach problems. These can happen especially at the start of treatment and may decrease over time. Call your doctor if these symptoms bother you or do not go away.


These are not all the possible side THE # 1


effects of Tecfidera. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. For more information go to dailymed.nlm.nih.gov.


Tell your doctor if you are pregnant or plan to become pregnant, or breastfeeding or plan to breastfeed. It is not known if Tecfidera will harm your unborn baby or if it passes into your breast milk. Also tell your doctor if you are taking prescription or over-the-counter medicines, vitamins, or herbal supplements.


For additional important safety information, please see Patient Information on the following page. This is not intended to replace


discussions with your doctor. *





During a 2-year study, Tecfidera cut relapses in half, reducing the risk of relapse by 49% compared to placebo.


Based on number of prescriptions from IMS NPA™


Weekly Data (September 27, 2013 - September 19, 2014). PRESCRIBED PILL for relapsing MS in the US since September 2013.† Visit TecfideraPill.comor call 1-844-TalkTec (1-844-825-5832)


© 2014 Biogen Idec. All rights reserved. 11/14 TEC-US-0128 225 Binney Street, Cambridge, MA 02142 • 1-800-456-2255 • Tecfidera.com


© PARADE Publications 2014. All rights reserved


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20